Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Establishing First Trimester Markers for the Identification of High Risk Twin

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT02031393
First received: January 8, 2014
Last updated: January 30, 2014
Last verified: December 2013

January 8, 2014
January 30, 2014
September 2009
January 2014   (final data collection date for primary outcome measure)
The development of preeclampsia [ Time Frame: after delivery ] [ Designated as safety issue: No ]
the women will be approached after birth to asses whether they developed preeclampsia or pregnancy induced hypertension
Same as current
Complete list of historical versions of study NCT02031393 on ClinicalTrials.gov Archive Site
intra uterine growth restriction [ Time Frame: after delivery ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Establishing First Trimester Markers for the Identification of High Risk Twin
Establishing First Trimester Sonographic, Biochemical and Clinical Markers for the Identification of High Risk Twin in the First Trimester

The purpose of this study is to determine whether we can establish different markers suc as mean arterial pressure , flow in the uterine arteries, biochemical markers in maternal blood and more un the first trimester, in order to screen for twin pregnancies that are more likely to develop adverse pregnancy outcome: early delivery, pre eclampsia or small fetuses.

Not Provided
Observational [Patient Registry]
Observational Model: Case Control
Time Perspective: Prospective
9 Months
Retention:   Samples Without DNA
Description:

Maternal serum

Non-Probability Sample

pregnant women that will come to our first trimester clinic inorder to preform first trimester screeninig

  • Small for Gestational Age (Disorder)
  • Pre-Eclampsia
Not Provided
  • singelton pregnancy
    will be followed 11-14 weeks and 19-28 weeks of gestation and after birth
  • twin pregnancy
    will be followed 11-14 weeks and 19-28 weeks of gestation and after birth
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
300
July 2014
January 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • pregnant women from 11 -14 weeks of gestation

Exclusion Criteria:

  • nuchal thickness above 3 mm,
  • Chronic hypertension,
  • thrombophilia,
  • Diabetes
Female
18 Years to 50 Years
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT02031393
217/13
No
Assaf-Harofeh Medical Center
Assaf-Harofeh Medical Center
Not Provided
Not Provided
Assaf-Harofeh Medical Center
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP